• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-07-25

  This study presents a systematically optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), integrating refined culture conditions and small molecule modulators to enhance yield, shorten differentiation time, and dramatically reduce costs. The findings have significant implications for scalable platelet production relevant to regenerative medicine and cell therapy.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor for Advanc

  2026-07-24

  GKT137831, a nanomolar dual NADPH oxidase Nox1/Nox4 inhibitor, redefines oxidative stress research with robust, selective inhibition suited for fibrosis, vascular remodeling, and metabolic disease models. This guide details real-world protocols, data-driven troubleshooting, and workflow strategies, integrating the latest insights from redox biology and ferroptosis research.

• Masitinib (AB1010): Technical Guidance for KIT/PDGFR Researc

  2026-07-24

  Masitinib (AB1010) is a highly selective tyrosine kinase inhibitor for precise inhibition of KIT, PDGFRα, and PDGFRβ signaling in cancer biology, mastocytosis, and inflammatory disease research. It is not suitable for protocols demanding aqueous or ethanol solubility, or for studies requiring broad-spectrum kinase inhibition.

• Neuroinflammatory Mechanisms in Trigeminal Neuralgia: The CG

  2026-07-23

  Liao et al. elucidate how trigeminal nerve root compression drives mechanical allodynia in trigeminal neuralgia through a Ca2+-dependent neuroinflammatory cascade involving the CGRP/SP-Piezo2 axis. Their integrative approach highlights novel molecular intersections between sensory neuron signaling and peripheral inflammation, providing a mechanistic foundation for targeted modulation in neuropathic pain research.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Bioma

  2026-07-23

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody empowers sensitive, reproducible biomarker detection across immunofluorescence, flow cytometry, and advanced proteomics workflows. Its superior signal amplification and background reduction enable confident early-stage disease monitoring, as exemplified in recent diabetic nephropathy biomarker research.

• Lipidomic Shifts Sensitize Persister Cancer Cells to Ferropt

  2026-07-22

  This study reveals that persister cancer cells acquire a distinct lipid profile—enriched in diPUFA phospholipids and polyunsaturated free fatty acids—that renders them highly sensitive to ferroptosis. The findings highlight mitochondria-dependent lipidomic remodeling as a driver of this vulnerability, offering new avenues for targeting drug-tolerant cancer subpopulations.

• Affinity-Purified Goat Anti-Mouse IgG (H+L): HRP Conjugated

  2026-07-22

  The Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated antibody from APExBIO delivers unmatched sensitivity and reproducibility in immunodetection workflows. By enabling robust signal amplification and simplifying troubleshooting, this secondary antibody accelerates discovery in mitochondrial, metabolic, and cardiovascular research.

• CCG-1423: RhoA Inhibitor Workflows for Cancer & Virology

  2026-07-21

  CCG-1423 enables targeted dissection of RhoA signaling in both cancer and viral models, bridging tight junction biology and apoptosis research. This guide delivers workflow enhancements, troubleshooting insights, and actionable parameters for maximizing the impact of APExBIO’s selective RhoA inhibitor.

• BAPTA Calcium Chelator: Precision Modulation in Apoptosis Re

  2026-07-21

  Harnessing BAPTA’s high-affinity calcium chelation allows researchers to dissect calcium-dependent apoptosis mechanisms with unprecedented precision. This guide translates recent breakthroughs in environmental toxicology and signaling pathway modulation into actionable workflows, troubleshooting, and advanced assay design.

• Distinct Death Pathways in ALL Cells After Microtubule Disru

  2026-07-20

  This study reveals that primary acute lymphoblastic leukemia (ALL) cells undergo fundamentally different cell death mechanisms depending on whether microtubule depolymerization occurs in G1 or M phase. These findings reshape our understanding of microtubule targeting agent (MTA) action and carry implications for apoptosis assay design and translational cancer biology.

• Rapid Purification of Recombinant Annexin V for Biophysical

  2026-07-20

  This study introduces a streamlined and highly effective method for purifying recombinant annexin V, a pivotal protein in ion channel and membrane biology research. The protocol achieves exceptional purity by leveraging calcium-dependent liposome binding and gentle bacterial cell lysis, enhancing the reliability of subsequent biophysical investigations.

• Renal Blood Flow Dynamics in Septic Rats Treated with K+ Cha

  2026-07-19

  This study elucidates how administration of norepinephrine and phenylephrine, in conjunction with selective and non-selective K+ channel blockers, affects renal blood flow in a sepsis model. The findings reveal maladaptive renal vascular responses to adrenergic stimulation when KCa1.1 and Kir6.1 channels are pharmacologically blocked, with implications for sepsis-associated acute kidney injury and translational research models.

• Oteseconazole (VT-1161): Optimizing Antifungal Workflows for

  2026-07-18

  Oteseconazole (VT-1161) offers unmatched selectivity and potency for in vitro Candida research, especially in fluconazole-resistant strains. This guide details protocol parameters, troubleshooting strategies, and cross-study insights to help scientists design robust antifungal assays and minimize drug interaction risks.

• G007-LK Tankyrase 1/2 Inhibitor: A Transformative Tool for T

  2026-07-17

  Explore the unique potential of G007-LK, a potent tankyrase 1/2 inhibitor, for precision modulation of the Wnt/β-catenin pathway in APC-mutant cancer models. This article delivers a practical, protocol-driven analysis that advances research beyond current mechanistic summaries.

• Metal-Ion-Chelating l-Phe Nanostructures Enhance ICB Therapy

  2026-07-17

  This study presents metal-ion-chelating l-phenylalanine nanostructures as a strategy to remodel the immunosuppressive tumor microenvironment and sensitize breast tumors to immune checkpoint blockade (ICB) therapy. The findings highlight a mechanistic link between dendritic cell activation and improved anti-tumor immunity, offering new avenues to overcome resistance in cancer immunotherapy.

464 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page